Sequenex Achieves ISO 13485 Certification for its Quality Management System
FOR IMMEDIATE RELEASE: Sequenex announces it has received ISO 13485 certification for its quality management system.
FDA Releases its Final Guidance on Premarket Submissions for Device Software Functions
The FDA has released its final guidance on Premarket Submissions for Device Software Functions. Find out how this guidance differs from the previous version and what it means for the development and approval of your SaMD or medical device.
GlucoRX BioXensor Raises Bar for Multi-Sensor Devices
The GlucoRX BioXensor uses multiple built-in sensors to provide real-time blood glucose readings while tracking heart rate, temperature, movement, and more. Find out why we think devices like this one could revolutionize the wearables market.
Embecta-Tidepool Partnership Highlights Opportunities in Type 2 Diabetes Market
Embecta has partnered with Tidepool to create a type-2-specific AID insulin pump system. This move highlights a quickly growing market with the potential for lucrative future opportunities.
Meet Sequenex at this Year’s ADA Scientific Sessions
Sequenex is heading to the 2023 American Diabetes Association Scientific Sessions in June. Stop by our booth to learn about our services and find out how we can help your company develop innovative connected software solutions.
Abbott Pain Relief System with Connected App Receives FDA Approval
Abbott’s Proclaim XR SCS integrates with a useful smartphone application. Its success highlights the importance of seamless connectivity in modern medical devices.